fusidic acid has been researched along with Bone Diseases, Infectious in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Desplaces, N; Dzeing-Ella, A; Kitzis, MD; Mamoudy, P; Zeller, V; Ziza, JM | 1 |
Aubin, GG; BĂ©mer, P; Corvec, S; Geffroy, L; Guillouzouic, A; Launay, E; Touchais, S | 1 |
Chang, MC; Chen, YH; Chiu, FY; Hsieh, PH; Hsueh, PR; Huang, CT; Hwang, KP; Ko, WC; Lau, YJ; Liu, CL; Liu, CP; Liu, CY; Tang, HJ; Wang, CT; Wang, JL | 1 |
Atkins, B; Gottlieb, T | 1 |
2 review(s) available for fusidic acid and Bone Diseases, Infectious
Article | Year |
---|---|
Fusidic acid for the treatment of bone and joint infections caused by meticillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Asia; Bone Diseases, Infectious; Doxycycline; Drug Resistance, Bacterial; Fusidic Acid; Humans; Joint Diseases; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections | 2012 |
Fusidic acid in bone and joint infections.
Topics: Animals; Anti-Bacterial Agents; Arthritis, Infectious; Bone Diseases, Infectious; Child; Fusidic Acid; Humans; In Vitro Techniques; Joint Diseases; Methicillin Resistance; Osteomyelitis; Prosthesis-Related Infections; Staphylococcal Infections; Staphylococcus aureus | 1999 |
2 other study(ies) available for fusidic acid and Bone Diseases, Infectious
Article | Year |
---|---|
Continuous clindamycin infusion, an innovative approach to treating bone and joint infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bone Diseases, Infectious; Clindamycin; Cohort Studies; Drug Interactions; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Joint Diseases; Male; Middle Aged; Retrospective Studies; Rifampin; Treatment Outcome; Young Adult | 2010 |
Failure of combination therapy for Staphylococcus aureus bone infection: a case of in vivo selection with resistance to rifampicin and fusidic acid.
Topics: Adolescent; Anti-Bacterial Agents; Bone Diseases, Infectious; Drug Resistance, Bacterial; Fusidic Acid; Humans; Male; Rifampin; Staphylococcal Infections; Staphylococcus aureus | 2016 |